New Presentation Time -- OMRIX Biopharmaceuticals to Webcast Presentation at C.E. Unterberg, Towbin Emerging Growth Conference; OMRIX to Present on Wednesday, July 12 at 3:55 PM, EDT

OMRIX Biopharmaceuticals, Inc. ("OMRIX" or "The
Company") (NASDAQ: OMRI), a commercial-stage biopharmaceutical company
that develops and markets biosurgical and passive immunotherapy
products, announced that its new presentation time at the C.E.
Unterberg, Towbin Emerging Growth Conference is 3:55 p.m. EDT at the
Mandarin Oriental Hotel in New York City, on Wednesday, July 12, 2006.
Michael Burshtine, Senior Vice President and Chief Financial Officer,
will give a company presentation.
A live webcast of the presentation will be available on the
Company's corporate web site at www.omrix.com. Participants are urged
to log on to the web site 15 minutes prior to the scheduled start time
to download and install any necessary audio software. A replay of the
webcast will be available immediately following the event and will
remain accessible for 30 days.

About OMRIX Biopharmaceuticals, Inc.

OMRIX, a commercial-stage biopharmaceutical company, develops and
markets innovative biosurgical and passive immunotherapy products,
utilizing its proprietary protein purification technology and
manufacturing know-how. As part of its business strategy, OMRIX
commercializes certain of its biosurgical products through
collaborations with companies whose marketing and sales expertise are
a complement to OMRIX's own areas of specialty. OMRIX's novel and
easy-to-use biological-device convergence products address unmet
medical needs. For more information, please visit: www.omrix.com.

Safe Harbor Statement

This press release contains forward-looking statements.
Forward-looking statements provide the company's current expectations
or forecasts of future events. Forward-looking statements include
statements about the company's expectations, beliefs, plans,
objectives, intentions, assumptions and other statements that are not
historical facts. Words or phrases such as ''anticipate,''
''believe,'' ''continue,'' ''ongoing,'' ''estimate,'' ''expect,''
''intend,'' ''may,'' ''plan,'' ''potential,'' ''predict,'' ''project''
or similar words or phrases, or the negatives of those words or
phrases, may identify forward-looking statements, but the absence of
these words does not necessarily mean that a statement is not
forward-looking.
Forward-looking statements are subject to known and unknown risks
and uncertainties and are based on potentially inaccurate assumptions
that could cause actual results to differ materially from those
expected or implied by the forward-looking statements. The company's
actual results could differ materially from those anticipated in
forward-looking statements for many reasons, including the factors
described in the sections entitled ''Risk factors'' and "Management's
discussion and analysis of financial condition and results of
operations" in the company's Prospectus as filed with the Securities
and Exchange Commission on April 21, 2006. Accordingly, you should not
unduly rely on these forward-looking statements, which speak only as
of the date of this press release.
Unless required by law, the company undertakes no obligation to
publicly revise any forward-looking statement to reflect circumstances
or events after the date of this press release or to reflect the
occurrence of unanticipated events. You should, however, review the
factors and risks we describe in the reports the company will file
from time to time with the Securities and Exchange Commission after
the date of this press release.